Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease

One out of every five hundred African American children in the United States has sickle cell disease (SCD). While multiple disease-modifying therapies are available, hematopoietic cell transplantation (HCT) remains the only curative option for children with SCD. HLA-matched sibling HCT has demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Limerick, Emily, Abraham, Allistair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267729/
https://www.ncbi.nlm.nih.gov/pubmed/35807140
http://dx.doi.org/10.3390/jcm11133856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267729/
https://www.ncbi.nlm.nih.gov/pubmed/35807140
http://dx.doi.org/10.3390/jcm11133856

Ejemplares similares